SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
on May 11 2021 6:00 AM
Test will detect infection of chlamydia and gonorrhoea and determine antimicrobial susceptibility to easy-to-access antibiotics within 60 minutes
SYDNEY (BUSINESS WIRE) #AntimicrobialStewardship SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, announced it has been awarded up to US $1.8 million from CARB-X, a global non-profit partnership dedicated to supporting research and development to address the rising threat of drug-resistant bacteria. SpeeDx represents the first Australian-based diagnostics company to receive CARB-X funding and a further $1.9 million will be available once the project reaches defined milestones. Funds will be used to develop a rapid test for the combined detection of
Will corporate greed prolong the pandemic?
May 10,2021 - Last updated at May 10,2021
By Joseph E. Stiglitz and Lori Wallach
NEW YORK The only way to end the COVID-19 pandemic is to immunise enough people worldwide. The slogan “no one is safe until we are all safe” captures the epidemiological reality we face. Outbreaks anywhere could spawn a SARS-CoV-2 variant that is resistant to vaccines, forcing us all back into some form of lockdown. Given the emergence of worrisome new mutations in India, Brazil, South Africa, the United Kingdom, and elsewhere, this is no mere theoretical threat.
Worse, vaccine production is currently nowhere close to delivering the 10-15 billion doses needed to stop the spread of the virus. By the end of April, only 1.2 billion doses had been produced worldwide. At this rate, hundreds of millions of people in developing countries will remain unimmunised at least until 2023.
by Tyler Durden
In 2015,
Chinese military scientists discussed how to weaponze SARS coronaviruses, five years before the COVID-19 pandemic emerged in Wuhan, China - where CCP scientists were collaborating with a US-funded NGO on so-called gain of function research to make bat coronaviruses infect humans more easily.
In a 263-page document, written by People s Liberation Army scientists and senior Chinese public health officials and
obtained by the US State Department during its investigation into the origins of COVID-19,
PLA scientists note how a sudden surge of patients requiring hospitalization during a bioweapon attack could cause the enemy’s medical system to collapse, according to
For decades, a rare disease crawled across Papua New Guinea. When scientists realized what was behind kuru, it caught everyone by surprise. But similar diseases can still be transmitted through food.
DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence
As the COVID-19 pandemic continues to send tremors across the medical fraternity by challenging therapeutic approaches, physicians and researchers are turning to existing drugs for answers. One such drug is Ivermectin. Now, a new review study has stated that the immediate use of the drug globally can end the SARS-CoV-2-caused pandemic.
The peer-reviewed study led by the Front Line COVID-19 Critical Care Alliance (FLCCC), scrutinized published peer-reviewed studies, expert meta-analyses, manuscripts, and epidemiological studies of areas with distribution efforts of Ivermectin. It concluded that Ivermectin is an effective treatment for COVID-19 as well as efficacious prophylaxis (preventive medication).